[Federal Register Volume 80, Number 19 (Thursday, January 29, 2015)]
[Notices]
[Pages 4922-4923]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-01680]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the Advisory Committee on Blood and Tissue Safety and
Availability
AGENCY: Department of Health and Human Services, Office of the
Secretary, Office of the Assistant Secretary for Health.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S.
Department of Health and Human Services is hereby giving notice that
the Advisory Committee on Blood and
[[Page 4923]]
Tissue Safety and Availability (ACBTSA) will hold a meeting. The
meeting will be open to the public.
DATES: The meeting will take place Tuesday April 7, 2105, from 8:00
a.m.-4:00 p.m. and Wednesday April 8, 2015, from 8:00 a.m.-3:30 p.m.
ADDRESSES: NIH Conference Room, 5635 Fishers Lane, Rockville, MD 20892.
FOR FURTHER INFORMATION CONTACT: Mr. James Berger, Designated Federal
Officer for the ACBTSA, Senior Advisor for Blood and Tissue Policy,
Office of the Assistant Secretary for Health, Department of Health and
Human Services, 1101 Wootton Parkway, Suite 250, Rockville, MD 20852.
Phone: (240) 453-8803; Fax (240) 453-8456; Email [email protected].
SUPPLEMENTARY INFORMATION: The ACBTSA provides advice to the Secretary
through the Assistant Secretary for Health. The Committee advises on a
range of policy issues to include: (1) Identification of public health
issues through surveillance of blood and tissue safety issues with
national biovigilance data tools; (2) identification of public health
issues that affect availability of blood, blood products, and tissues;
(3) broad public health, ethical and legal issues related to the safety
of blood, blood products, and tissues; (4) the impact of various
economic factors (e.g., product cost and supply) on safety and
availability of blood, blood products, and tissues; (5) risk
communications related to blood transfusion and tissue transplantation;
and (6) identification of infectious disease transmission issues for
blood, organs, blood stem cells and tissues. The Committee has met
regularly since its establishment in 1997.
The ACBTSA has made previous recommendations on the need to improve
tissue tracking and traceability. These recommendations focused on
tracking adverse events, creating a unique identifier for each donor,
and improving patient outcomes. Past recommendations made by the ACBTSA
may be viewed at www.hhs.gov/bloodsafety.
The focus of the meeting will be to address current issues in
tracking and traceability of tissue recovered from deceased donors. The
discussion will focus on pertinent federal and state regulations, other
mechanisms that impact tissue tracking and traceability, and current
gaps in this area. Presenters will represent a wide range of government
and non-government stakeholders, including federal agencies,
accreditation organizations, tissue and eye banks, healthcare
facilities, and medical practitioners.
The public will have an opportunity to present their views to the
Committee during a public comment session scheduled for April 8, 2015.
Comments will be limited to five minutes per speaker and must be
pertinent to the discussion. Pre-registration is required for
participation in the public comment session. Any member of the public
who would like to participate in this session is encouraged to contact
the Designated Federal Officer at his/her earliest convenience to
register for time (limited to 5 minutes) ; registration must be
completed prior to close of business on April 1, 2015. If it is not
possible to provide 30 copies of the material to be distributed at the
meeting, then individuals are requested to provide a minimum of one (1)
copy of the document(s) to be distributed prior to the close of
business on April 1, 2015. It is also requested that any member of the
public who wishes to provide comments to the Committee utilizing
electronic data projection submit the necessary material to the
Designated Federal Officer prior to the close of business on April 1,
2015.
Dated: January 22, 2015.
James J. Berger,
Senior Advisor for Blood and Tissue Safety Policy.
[FR Doc. 2015-01680 Filed 1-28-15; 8:45 am]
BILLING CODE 4150-41-P